GLP single dose toxicity study in dogs. Toxicological evaluations of potential medications. 09/13/24 - 09/12/25. Nida REF. No. N01DA-23-8939
Ended Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,487,646
Award facts
- Opportunity
-
- TORFP02 Solicitation number
- Contract value 84% obligated
-
- $1,487,646.00 Current, with exercised options
- $1,773,704.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,487,646 |
About this award
This is a federal contract award valued at $1,773,704.00 made by the National Institute on Drug Abuse (NIDA), a civilian agency, to SRI International, a non-profit research and development institute. The contract is for a GLP single dose toxicity study in dogs to support toxicological evaluations of potential medications. The contract has a period of performance from September 13, 2024 to September 12, 2026. This award does not have a set-aside designation. SRI International has a history of providing advanced scientific and technical services to the U.S. federal government, including research and development work for agencies such as the Defense Advanced Research Projects Agency (DARPA), National Institutes of Health (NIH), and Department of Defense.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 12, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $1,487,646 on 75N95024F00001. Its potential value, with all options, is $1,773,704.
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a delivery order under 75N95023D00023, an indefinite delivery contract.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award